MBS355898 | Anti-SARS-CoV-2 Nucleocapsid IgG/COVID-19, Humanized antibody (Positive Control)

Anti-SARS-CoV-2 Nucleocapsid IgG/COVID-19, Humanized antibody (Positive Control) | MBS355898 | Mybiosource

Product Short Name: [COVID 19 Nucleocapsid (NP) IgG Humanized Coronavirus]

Product Name Synonyme: [2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Nucleocapsid; Nucleoprotein (NP), IgG]

Other Names: N/A

Product Gene Name: [COVID-19]

Product Gene Name Synonyme: [2019-nCoV; SARS-CoV-2; SARS coronavirus 2 proteome; COVID19; SARS-CoV2]

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: Human IgG1

Clone: [3E2]

Host: Cultured in vitro

Reactivity: Viral

Specificity: N/A

Purity: Purity: >95% by HPLC & SDS-PAGE
Purification: Protein A purified

Form: Liquid; Supplied in 0.01 M PBS without preservative.

Concentration: N/A

Storage Stability: Aliquot and store at -20 degree C for long term (at least for one year). Avoid repeated freeze and thaw cycles.

Tested Application: Lateral Flow (Rapid Test). Researchers are responsible for verifying the compatibility of this positive control antibody with the antigen/recombinant protein used in their immunoassay.